Heptaologist, Assoc Professor of Medicine
Toronto Centre for Liver Disease, University of Toronto
Following clinical training in Internal Medicine and Gastroenterology and Hepatology, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Dr. Feld holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital and the Sandra Rotman Centre for Global Health at the University of Toronto. He leads a large clinical research team evaluating new therapeutics and diagnostics for hepatitis B and C virus infections and has led pivotal international trials to establish new treatment paradigms. He serves on the AASLD/IDSA hepatitis C treatment guidance panel and the Panamerican Health Organization Technical Advisory Group on Viral Hepatitis.
Disclosure: AbbVie: Consultant, Grant/Research Support; Alexion (Individual(s) Involved: Self): Grant/Research Support; Arbutus (Individual(s) Involved: Self): Consultant; Eiger (Individual(s) Involved: Self): Grant/Research Support; Gilead: Consultant, Grant/Research Support; GSK (Individual(s) Involved: Self): Consultant; Janssen: Grant/Research Support; Roche (Individual(s) Involved: Self): Consultant; Wako/Fujifilm (Individual(s) Involved: Self): Grant/Research Support
Thursday, October 22, 2020
12:30pm – 1:45pm EDT
